e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):      June 21, 2008
Emisphere Technologies, Inc.
 
(Exact name of registrant as specified in its charter)
         
Delaware   1-10615   13-3306985
         
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
     
240 Cedar Knolls Road, Suite 200,
Cedar Knolls, New Jersey 		  07927
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code:      973-532-8000
Not Applicable
 
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 1.01 Entry into a Material Definitive Agreement.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
Ex-99.1 Press release dated June 23, 2008

Table of Contents

Item 1.01   Entry into a Material Definitive Agreement.
On June 21, 2008, Emisphere Technologies, Inc. (the “Company”) entered into a Development and License Agreement with Novo Nordisk A/S (the “Agreement”) to develop and commercialize formulations of Novo Nordisk’s GLP-1 receptor agonists with the Company’s proprietary delivery agents. A copy of the press release announcing this Agreement is attached hereto as Exhibit 99.1 and the terms described therein are incorporated into this Form 8-K.
In addition, the Company will receive a payment of $10 million on or about July 1, 2008 under the terms of this Agreement.
Item 9.01   Financial Statements and Exhibits.
(d) Exhibits
     
Exhibit No.   Description
99.1
  Press Release dated June 23, 2008.

 

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  Emisphere Technologies, Inc.
 		  
June 23, 2008  By:   /s/ Michael R. Garone    
    Name:   Michael R. Garone   
    Title:   Chief Financial Officer   

 

Table of Contents

         
EXHIBIT INDEX
     
Exhibit No.   Description
99.1
  Press Release dated June 23, 2008.